Please provide your email address to receive an email when new articles are posted on . The newly presented data is from the two STOP-HS trials, both of which met their primary endpoints. Povorcitinib ...

As they gain data maturity, state and local agencies are increasingly putting their information to work. In Washington, D.C., a real-time information dashboard helps first responders manage blood used ...

As organizations seek to evolve their patient support programs, five key actions can help bridge the data gap between analytics teams and patient care teams: Data will always be essential in measuring ...

Results of two Chinese phase 3 trials presented at this year’s San Antonio Breast Cancer Symposium (SABCS) 2025 provide strong support for adjuvant carboplatin in early-stage triple-negative breast ...

Tocilizumab is effective and safe for rheumatoid arthritis, with long-term studies supporting its use and comparable cardiovascular risk to tumor necrosis factor inhibitors. Real-world data indicate ...

MANCHESTER, England — Febuxostat (Uloric) did not appear to increase the risk for major adverse cardiovascular (CV) events (MACEs) when compared with no urate-lowering therapy (ULT) in people with ...

In today’s interconnected and competitive business environment, organizations with a global footprint—particularly in industries like consumer packaged goods (CPG), manufacturing, and logistics—must ...

Lt. Gen. Paul Stanton, USA, commander, Joint Forces Headquarters-Department of Defense Information Network (JFHQ-DODIN) and director of the Defense Information Systems Agency (DISA), is building a ...